• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分泌过多型垂体瘤的经蝶窦手术:内分泌随访(作者译)

[Transsphenoidal surgery in hypersecreting pituitary tumors: endocrine follow-up (author's transl)].

作者信息

Guibout M, Jaquet P, Lissitzky J C, Grisoli F, Vincentelli F

出版信息

Ann Endocrinol (Paris). 1978;39(2):95-106.

PMID:687397
Abstract

Among 18 patients suffering prolactin adenoma and 16 acromegalic patients, plasma levels of PRL and HGH respectively returned to normal vlues (PRL = 9 +/- 2 ng/ml HGH = 4.2 +/- 0.8 ng/ml) immediately after selective removal of the pituitary adenoma by transsphenoïdal route. In all cases tumoral symptoms were reduced. Menses were recovered 36 +/- 5 days after surgery in all patients with prolactin adenoma. Pregnancy succeeded in nine of these women. Per-operative studies of HGH and PRL plasma variations proved to be of good prognostic value. The evaluation of the pituitary functions was performed before and after surgery. In no case pituitary deficiency occured after treatment. Furthermore the regulation of somatotropic and prolactin functions have been documented by the use of different provocative tests before and after treatment. They allow discussion of the pathogenecity of these hypersecreting tumors.

摘要

在18例催乳素腺瘤患者和16例肢端肥大症患者中,经蝶窦途径选择性切除垂体腺瘤后,血浆PRL和HGH水平分别立即恢复正常(PRL = 9 ± 2 ng/ml,HGH = 4.2 ± 0.8 ng/ml)。所有病例的肿瘤症状均减轻。所有催乳素腺瘤患者术后36 ± 5天月经恢复。其中9名女性成功怀孕。术中对HGH和PRL血浆变化的研究证明具有良好的预后价值。在手术前后对垂体功能进行了评估。治疗后无一例出现垂体功能减退。此外,通过治疗前后使用不同的激发试验记录了生长激素和催乳素功能的调节情况。这些试验有助于探讨这些分泌过多肿瘤的发病机制。

相似文献

1
[Transsphenoidal surgery in hypersecreting pituitary tumors: endocrine follow-up (author's transl)].分泌过多型垂体瘤的经蝶窦手术:内分泌随访(作者译)
Ann Endocrinol (Paris). 1978;39(2):95-106.
2
Neurosurgical management of acromegaly. Results in 82 patients treated between 1972 and 1977.肢端肥大症的神经外科治疗。1972年至1977年间对82例患者的治疗结果。
J Neurosurg. 1979 Apr;50(4):454-61. doi: 10.3171/jns.1979.50.4.0454.
3
Serum prolactin response to thyrotropin-releasing hormone and metoclopramide in patients with prolactin-secreting tumors before and after transsphenoidal surgery.经蝶窦手术前后泌乳素分泌性肿瘤患者血清泌乳素对促甲状腺激素释放激素和胃复安的反应。
J Clin Endocrinol Metab. 1978 Nov;47(5):1148-51. doi: 10.1210/jcem-47-5-1148.
4
Prolactin secretion in acromegalic patients before and after selective adenomectomy.肢端肥大症患者选择性腺瘤切除术前及术后的催乳素分泌情况。
J Clin Endocrinol Metab. 1985 Jul;61(1):104-9. doi: 10.1210/jcem-61-1-104.
5
[Proceedings: Studies of the pituitary gonadal axis in prolactin adenoma (author's transl)].[会议论文:泌乳素腺瘤中垂体性腺轴的研究(作者译)]
Ann Endocrinol (Paris). 1975 Nov-Dec;36(6):331-2.
6
[Endocrine prognosis of PRL-secreting pituitary adenomas. In 90 female cases (author's transl)].泌乳素分泌型垂体腺瘤的内分泌预后。90例女性病例(作者译)
Ann Endocrinol (Paris). 1980 Jan-Feb;41(1):57-8.
7
Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas.大型无功能垂体腺瘤患者的可逆性垂体功能减退
J Clin Endocrinol Metab. 1986 Jun;62(6):1173-9. doi: 10.1210/jcem-62-6-1173.
8
[Prolactin secreting adenomas: surgical treatment and results. 120 female cases, 30 males cases (author's transl)].[催乳素分泌性腺瘤:手术治疗及结果。120例女性病例,30例男性病例(作者译)]
Nouv Presse Med. 1979 Feb 17;8(8):577-83.
9
Selective transsphenoidal adenomectomy in women with galactorrhea-amenorrhea.患有溢乳-闭经的女性的选择性经蝶窦腺瘤切除术。
JAMA. 1979 Jul 13;242(2):158-62.
10
Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly.生长激素动态变化及生长调节素C(胰岛素样生长因子I)水平在预测肢端肥大症经蝶窦手术后长期疗效中的价值。
J Lab Clin Med. 1987 Mar;109(3):346-54.

引用本文的文献

1
Prolactinoma through the female life cycle.催乳素瘤贯穿女性生命周期。
Endocrine. 2018 Jan;59(1):16-29. doi: 10.1007/s12020-017-1438-7. Epub 2017 Nov 24.
2
Present status of neurosurgery in the treatment of prolactinomas.
Neurosurg Rev. 1985;8(3-4):195-205. doi: 10.1007/BF01815444.